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Abstract Boron Neutron Capture Therapy (BNCT) is an effective and promising treatment of tumour types which are 
resistant to conventional therapies. The characteristics of boron neutron capture therapy (BNCT) for cancer treatment 
demand, in addition to sufficient fluxes of epithermal neutrons, proper conditions of the neutron sources—compact 
layout, flexible operation, compatibility with hospital setting, etc. The lack of proper neutron sources that can be applied 
to the infrastructure of hospital or clinical facilities is a major problem. Compact neutron generators (CNGs), which 
are the most compact and least expensive, were a potential, alternative, solution to existing BNCT treatment facilities 
based on nuclear reactors. This paper will provide information about the latest CNGs technology development that has 
contributed to the Boron Neutron Capture Therapy (BNCT) technology improvement. 
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INTRODUCTION 
Boron Neutron Capture Therapy (BNCT) 
is a very promising treatment for patients 
suffering from glioblastoma multiform, an 
aggressive type of brain cancer, where 
conventional radiation therapies fail 
(Fantidis, J.G., et.al. 2013). Boron neutron 
capture therapy (BNCT) which bases a 
cancer treatment on the neutron-capture 
reaction of 10B(n,D)7Li is by far the most 
researched modality among all the possible 
neutron-capture therapeutic processes. 
BNCT is a binary treatment modality, first 
a 10B compound is delivered to the patient 
and is accumulated differently in cancer cells 
than healthy tissue; then, when a high boron 
concentration ratio between tumor and 
healthy issue is reached, the patient is 
irradiated with neutrons inducing the 
10B(n,α)7Li reaction. The alpha particle 
emitted and the 7Li nuclei created have high 
Linear Energy Transfer (LET), and an 
associated high Relative Biological 
Effectiveness (RBE) α particle, ≈150 
keV/μm and ≈175 keV/μm for 7Li ion 
(Moss, R.L., 2014). The mean free path is 
about 7 μm and 4 μm for α particle and for 
7Li, respectively (Fantidis, J.G., et al., 2013; 
Fantidis J.G., and Antoniadis A. 2015). 
Hence their energy deposition is limited to 
the diameter of a single cell. Therefore, it is 
possible to selectively irradiate cancer cells 
that have taken up a sufficient amount of 
10B, while simultaneously sparing normal, 
healthy cells (Moss, R.L., 2014). 
Clearly, BNCT is a complex, 
multidisciplinary enterprise, encompassing 
the fields of neutron sources, 
pharmaceuticals, medical imaging, 
radiobiology, and clinical planning and 
implementation. In spite of a long history of 
research first conceived in 1930s and of 
experimentation in early 1950s, progress of 
BNCT so far has fallen behind the photon- 
and ion-beam therapies in practical 
prevalence and treatment scope. For 
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example, preclinical trials and treatments to 
date have taken place only at improvised 
neutron-delivery stations at fission-reactor 
sources that are not entirely devoted to 
medical purposes. Only two 10B-carrying 
drugs have been approved for treating head 
and neck cancers. The lack of proper neutron 
sources that can be integrated to the 
infrastructure of hospital or clinical facilities 
is a major problem (Loong, C.-K., et.al. 
2014). 
A compact neutron source based on 
2H(d,n)3He (D-D) or the 3H(d,n)4He (D-T) 
fusion reactions yielding 2.45 MeV and 14.1 
MeV neutrons, respectively, has been 
suggested for BNCT use. These reactions 
have positive Q values and thus, low 
bombarding energy is required in 
comparison to the other neutron-producing 
reactions. The fusion neutron source is 
compact in size and also safe for hospital use. 
The fusion-based neutron sources are 
commercially available. Such neutron 
sources used to be very common in neutron 
research facilities and at universities, and 
thus, the technology required is well known. 
(Koivunoro, H. 2012). A CNG 
accommodates the ion source, electron 
shield, acceleration structure and a target in 
a single housing. Thus they are substantially 
smaller and less expensive than 
accelerators/reactors. (Loong, C.-K., et.al.). 
The drawback is the production of fast 
neutrons at considerably lower neutron 
fluxes. The modern target uses a deuterium 
(D+) or tritium (T+) absorbing material such 
as titanium backed by liquid cooled copper. 
The titanium readily absorbs the D+ or T+ 
ions forming a titanium hydride. Succeeding 
D+ or T+ ions strike these embedded ions 
and fuse, resulting in (d,d), (T,d) or (t,t) 
reactions and releasing fast neutrons. 
(Loong, C.-K., et.al. 2014) 
 
2. MATERIALS AND METHODS 
2.1 Compact Neutron Generators 
Compact NGs are becoming an attractive 
alternative to nuclear reactors and 
radioactive neutron sources in a variety of 
fields of neutron science, medical research 
and various material analysis applications. 
Traditionally compact NGs have been used 
in oil well logging industry, using DT fusion 
reaction for high energy 14 MeV neutron 
production. These NGs generate DT neutron 
yield in the range of 108 to 1011 n/s. There 
are yet others, which are made by 
universities or national laboratories, like 
VNIIA made generators (sold in US by Del 
Mar Ventures) and Lawrence Berkeley 
National Laboratory’s Plasma and Ion 
Source Technology Group (generators 
commercialized by Adelphi Technology 
Inc.) (Anonim A., 2012) 
The Plasma and Ion Source Technology 
Group (P&IST) at the E.O. Lawrence 
Berkeley National Laboratory has been 
developing high power DD NGs for various 
applications. These NGs are differentiated 
from the commercial manufacturers mainly 
by the method by which the plasma is 
generated and by the use of DD, instead of 
DT, fusion reaction (Anonim A., 2012). 
Those two kinds of Compact Neutron 
Generators will be the main focus in this 
article. 
The information gathered about the CNGs 
development progress were based on the last 
5 years of research which were made 
possible and affordable through Universitas 
Gadjah Mada direct access.
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3. RESULTS AND DISCUSSION 
Both D-D and DT CNGs have advantages 
and disadvantages. These challenges 
triggered scientists and engineers to develop 
the technology. The latest are shown below. 
 
3.1 D-D Compact Neutron Generators 
An extensive set of calculations performed 
with MCNP4B Monte Carlo code in 2013 
have shown that the combination of TiF3 
which integrates a conic part made of D2O, 
then followed by a TiF3 layer is the optimum 
moderator design. The use of BiF3 as 
spectrum shifter and γ rays filter, Titanium as 
fast neutron filter and Lithium as thermal 
neutron filter is necessary in order to obtain 
an epithermal neutron beam with high 
quality. The materials considered for the 
design of the facility, were chosen according 
to the EU Directive 2002/95/EC, hence, the 
use of cadmium and lead was excluded. The 
simulations show that, even if the neutron 
flux is below the recommended value for 
clinical treatment, the proposed facility is a 
good alternative for clinics which cannot 
afford to build and maintain a small nuclear 
reactor. (Fantidis, J.G., et.al. 2013). 
In the same year optimization of the Beam 
Shaping Assembly (BSA) has been 
performed using the MCNP4C Monte Carlo 
code in Iran to shape the 2.45 MeV neutrons 
that are produced in the D–D neutron 
generator. Optimal design of the Beam 
Shaping Assembly (BSA) has been chosen 
by considering in-air figures of merit (FOM) 
which consists of 70 cm Fluental as a 
moderator, 30 cm Pb as a reflector, 2 mm 6Li 
as a thermal neutronfilter and 2 mm Pb as a 
gamma filter. The neutron beam can be 
evaluated by in-phantom parameters, from 
which therapeutic gain can be derived. Direct 
evaluation of both set of FOMs (in-air and in- 
phantom) is very time consuming. In this 
research a Response Matrix (RM) method 
has been suggested to reduce the computing 
time. This method is based on considering the 
neutron spectrum at the beam exit and 
calculating contribution of various dose 
components in phantom to calculate the 
Response Matrix. Results show good 
agreement between direct calculation and the 
RM method. (Kasesaz, Y., et.al. 2013) 
 
3.2 D-T Compact Neutron Generators 
A Boron Neutron Capture Therapy 
(BNCT) facility based on a DT neutron 
generator was optimized by designing the 
beam-shaping assembly. With the aim of the 
MCNP4B Monte Carlo code different beam- 
shaping assembly (BSA) configurations were 
considered. Lead was selected as reflector 
material while CF2, D2O, Fluental, PbF4, 
PbF2, BiF3, BiF5, MgF2, Al2O3, AlF3, TiF3, 
BeD2, CaF2 and 
7LiF were examined as 
spectrum shifters. In order to improve the 
quality of the beam titanium, nickel-60, iron 
and titanium alloy (Ti6Al14V) were 
simulated as fast neutrons filters while lead 
and bismuth were considered as gamma 
filters. An extensive set of calculations 
performed with MCNP4B Monte Carlo code 
have shown that the combination of 7LiF 
which accommodates a conic part made of 
D2O, then followed by a TiF3 layer is the 
optimum moderator design. The use of three 
different materials for further reduction of 
fast neutrons, thermal neutrons and gamma 
rays is necessary. 60Ni, Cd and Bi were 
chosen respectively for these purposes. The 
epithermal neutron flux obtained at the beam 
exit window turned out to be 3.94×109 n 
cm‐ 2 s‐ 1 while fulfilling all the 
recommended IAEA in‐ air Figure of Merit 
(FOM) criteria. The assessment of the dose 
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profiles in head phantom and the 
in‐ phantom FOM are also presented. The 
proposed assembly configuration may 
provide an attractive option for centers 
wishing to install a BNCT facility (Fantidis 
J.G., et.al. 2015). 
Rasouli and Masoudi designed The BSA 
for optimization in 2011 and continued in 
2014 to simulate many configuration 
material for BSA. The results show that 
considering these limits together with the 
widely accepted IAEA criteria makes it 
possible to have a more realistic 
assessment of sufficiency of the designed 
beam. Satisfying these criteria not only 
leads to reduction of delivered dose to skin, 
but also increases the advantage depth in 
tissue and delivered dose to tumor during 
the treatment time. Other research of 
evaluation of BSA design of DD CNGs that 
had been designed by Rasouli and Masoudi 
in 2012 were conducted in Thailand. Three 
BSA designs based on the D-T reaction for 
BNCT are discussed. It is found that the 
BSA configuration designed satisfies all of 
the International Atomic Energy Agency 
(IAEA) criteria. It consists of 14 cm 
uranium as multiplier, 23 cm TiF3 and 36 
cm Fluental as moderator, 4 cm Fe as fast 
neutron filter, 1 mm Li as thermal neutron 
filter, 2.6 cm Bi as gamma ray filter, and Pb 
as collimator and reflector. It is also found 
that use of specific filters is important for 
removing the fast and thermal neutrons and 
gamma contamination (Asnal M, et al. 
2014). 
The feasibility of boron neutron capture 
therapy (BNCT) for liver tumor with four 
sealed neutron generators as neutron source 
had been researched. Two generators are 
placed on each side of the liver. The high 
energy of these emitted neutrons should be 
reduced by designing a beam shaping 
assembly (BSA) to make them useable for 
BNCT. However, the neutron flux decreases 
as neutrons pass through different materials 
of BSA. Therefore, it is essential to find ways 
to increase the neutron flux. The feasibility 
of using low enrichment uranium as a 
neutron multiplier is investigated to increase 
the number of neutrons emitted from D-T 
neutron generators. The neutron spectrum 
related to our system has a proper epithermal 
flux, and the fast and thermal neutron fluxes 
comply with the IAEA recommended values. 
Four generators are used at the same time to 
form a yield of 4×1011 n/s and two 
generators are placed on each side of the 
liver. A beam shaping assembly for BNCT is 
designed based on the use of low enrichment 
uranium as multiplier system for D–T 
neutron source. According to our results, a 20 
cm thickness of AlF3 as the first moderator 
and a 22 cm thickness of fluent is the best 
option for the moderator to achieve a proper 
epithermal neutron flux. The study of the 
beam quality shows that using a layer of thin 
6LiF filter to remove thermal neutrons and 
Bi to reduce gamma contamination is 
necessary to meet the free beam port 
parameters by IAEA (Zheng Liu, et.al. 2014). 
 
4. CONCLUSION 
Much of the research that has been 
conducted in the last 5 years major was to 
explore about increasing the configuration 
materials for BSA in order to meet the IAEA 
recommendation of neutron output which 
will be used for treatment and reducing 
unuseful output. The other studies related to 
BNCT are still in progress, such as 
dosimetry, detection and protection 
radiation, nuclear security, economic aspect, 
and affordability for hospital to install this 
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facility.   Comprehensive   research   is still 
required to make this technology feasible 
to install and sustain. In other words, 
Indonesia still has a wide opportunity to 
conduct more research in order to 
contribute and improve this advanced 
cancer therapy. 
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